Skip to main content
. 2023 May 26;11:1188905. doi: 10.3389/fcell.2023.1188905
iPSCs induced pluripotent stem cells
ESCs embryonic stem cells
PD Parkinson’s disease
AD Alzheimer’s disease
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
COVID-19 coronavirus disease 2019
hPSCs human pluripotent stem cells
EB embryoid body
APOE Apolipoprotein E
iPSC-LBs iPSC-derived liver buds
CF cystic fibrosis
F508del deletion of phenylalanine at position 508
CNS central nervous system
CFTR CF transmembrane conductance regulator
FGF fibroblast growth factor
OCA obeticholic acid
BMP4 bone morphogenetic protein 4
CS cytokine storm
BRD bromodomain-containing protein
BETi bromodomain and extra-terminal family inhibitors
FDA Food and Drug Administration
ACE2 angiotensin-converting enzyme 2
AT2 alveolar type 2
SFTPB surfactant protein B
MPA mycophenolic acid
QNHC quinacillin hydrochloride
CRT cell replacement therapy